In a murine tumor model, MIP treatment increases the infiltration and activation of CD4+, CD8+ T cells, NK and NKT cells as well as APCs resulting in secretion of Th1 type pro-inflammatory cytokines in TME. This evidence concerns the gene CD8A and neoplasm.